Cargando…

FMO4 shapes immuno‐metabolic reconfiguration in hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Luo, Yan, Chen, An‐Na, Fu, Jian‐Tao, Zhou, Gang, Wang, Jie, Zhou, Xiang, Yang, Jin, Shi, Jun‐Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858612/ https://www.ncbi.nlm.nih.gov/pubmed/35184417 http://dx.doi.org/10.1002/ctm2.740

Ejemplares similares

Revisiting the optical properties of the FMO protein
por: Milder, Maaike T. W., et al.
Publicado: (2010)

Pediculus Humanus Capitis in an Immuno Compromised Patient
por: Bloom, P. A., et al.
Publicado: (1989)

Is Immuno-modulation the Key to COVID-19 Pandemic?
por: Gupta, Ajay
Publicado: (2020)

Discovery of the Odderon by TOTEM experiments and the FMO approach
por: Martynov, Evgenij, et al.
Publicado: (2019)

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
por: El-Serafi, Ibrahim, et al.
Publicado: (2017)

Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer
por: Luo, Zhi-Wen, et al.
Publicado: (2023)

FMO rewires metabolism to promote longevity through tryptophan and one carbon metabolism in C. elegans
por: Choi, Hyo Sub, et al.
Publicado: (2023)

How to Face COVID-19 Outbreak: Reconfiguration of a Private Radiological Clinic
por: Cellina, Michaela, et al.
Publicado: (2020)

Correction: Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
Publicado: (2017)

Nicotine Dependence is Associated with Functional Variation in FMO3, an Enzyme that Metabolizes Nicotine in the Brain
por: Teitelbaum, Aaron M., et al.
Publicado: (2017)

Fluorescence-excitation and Emission Spectroscopy on Single FMO Complexes
por: Löhner, Alexander, et al.
Publicado: (2016)

T329S Mutation in the FMO3 Gene Alleviates Lipid Metabolic Diseases in Chickens in the Late Laying Period
por: Song, Jianlou, et al.
Publicado: (2021)

Metabolic reconfiguration enables synthetic reductive metabolism in yeast
por: Yu, Tao, et al.
Publicado: (2022)

The landscape of m(6)A regulators in small cell lung cancer: molecular characteristics, immuno-oncology features, and clinical relevance
por: Zhang, Chaoqi, et al.
Publicado: (2021)

Modelling and Control of a Reconfigurable Robot for Achieving Reconfiguration and Locomotion with Different Shapes
por: Samarakoon, S. M. Bhagya P., et al.
Publicado: (2021)

Stimuli-Responsive Microjets with Reconfigurable Shape**
por: Magdanz, Veronika, et al.
Publicado: (2014)

Reconfigurable Radiation Angle Continuous Deflection of All-Dielectric Phase-Change V-Shaped Antenna
por: Tang, Ping, et al.
Publicado: (2022)

Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer
por: Wu, Lichun, et al.
Publicado: (2023)

Effects of FMO3 Polymorphisms on Pharmacokinetics of Sulindac in Chinese Healthy Male Volunteers
por: Tang, Yong-Jun, et al.
Publicado: (2017)

Production of drug metabolites by human FMO3 in Escherichia coli
por: Catucci, Gianluca, et al.
Publicado: (2020)

GPRC5D as a promising therapeutic target in EGFR-wild and immuno-cold non-small cell lung cancer
por: Mei, Jie, et al.
Publicado: (2023)

Comparison of ImmunoCAP and Immulite serum specific IgE assays for the assessment of egg allergy
por: Graham, François, et al.
Publicado: (2016)

New insights in phenotype and treatment of lung disease immuno-deficiency and chromosome breakage syndrome (LICS)
por: Willemse, Brigitte W. M., et al.
Publicado: (2021)

Laser reprogramming magnetic anisotropy in soft composites for reconfigurable 3D shaping
por: Deng, Heng, et al.
Publicado: (2020)

Author Correction: Metabolic reconfiguration enables synthetic reductive metabolism in yeast
por: Yu, Tao, et al.
Publicado: (2023)

Rheumatic Immuno-related Adverse Events following Immunotherapy with Checkpoint Inhibitors: Adverse Drug Reaction, or Other?
por: Manzo, Ciro
Publicado: (2021)

FMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
por: Li, Xingzheng, et al.
Publicado: (2022)

Additional information on “Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for (89)Zr-immunoPET”
por: Raavé, René, et al.
Publicado: (2019)

Metabolomic and transcriptomic analyses of Fmo5(-/)(- )mice reveal roles for flavin-containing monooxygenase 5 (FMO5) in NRF2-mediated oxidative stress response, unfolded protein response, lipid homeostasis, and carbohydrate and one-carbon metabolism
por: Phillips, Ian R., et al.
Publicado: (2023)

Hybrid QM/MM study of FMO complex with polarized protein-specific charge
por: Jia, Xiangyu, et al.
Publicado: (2015)

Inactivation mechanism of N61S mutant of human FMO3 towards trimethylamine
por: Gao, Chongliang, et al.
Publicado: (2017)

Drug metabolite synthesis by immobilized human FMO3 and whole cell catalysts
por: Gao, Chongliang, et al.
Publicado: (2019)

Association of FMO3 Variants with Blood Pressure in the Atherosclerosis Risk in Communities Study
por: Bryant, Tyler S., et al.
Publicado: (2019)

Investigating the biochemical signatures and physiological roles of the FMO family using molecular phylogeny
por: Nicoll, C.R., et al.
Publicado: (2023)

FMO family may serve as novel marker and potential therapeutic target for the peritoneal metastasis in gastric cancer
por: Gong, Xumeng, et al.
Publicado: (2023)

Compliant rolling-contact architected materials for shape reconfigurability
por: Shaw, Lucas A., et al.
Publicado: (2018)

The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing
por: Gonzalez Malagon, Sandra G., et al.
Publicado: (2015)

Clinical significance of soluble programmed cell death‐ligand 1 in hepatitis B virus‐related hepatocellular carcinoma
por: Yang, Zhongxia, et al.
Publicado: (2023)

SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: Recommendations from the French society for ImmunoTherapy of Cancer (FITC)
por: Gauci, Marie-Léa, et al.
Publicado: (2021)

Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
por: Seban, Romain-David, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0rm89cb31hlgi3gi3h0bdvij5t